Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.34
-21.2 %
$ 8.12 M
Market Cap
-0.22
P/E
PRPH - TOTAL LIABILITIES
Total Liabilities PRPH - ProPhase Labs, Inc.
42.5 M
LAST VALUE
17.78%
2 YEAR CAGR
58.65%
5 YEAR CAGR
24.32%
10 YEAR CAGR